Veltride 0.5mg contains dutasteride in a 0.5mg oral formulation. Dutasteride inhibits both type 1 and type 2 5-alpha-reductase enzymes, reducing the conversion of testosterone into dihydrotestosterone. This broad DHT-lowering activity is relevant to medical treatment of benign prostatic hyperplasia and other specialist uses where dutasteride has been selected.

The product should be regarded as a prescription medicine requiring an appropriate clinical context rather than a general hair-care supplement. Dutasteride can remain in the body for an extended period, so changes in dosing should be discussed with a qualified healthcare professional. Consistent adherence and suitable follow-up help keep treatment decisions informed and safe